sustained release

(redirected from Sustained-release)
Also found in: Dictionary, Acronyms, Wikipedia.

sustained release

The delivery of a drug from a tablet or other reservoir over many hours or days (instead of minutes or hours), to provide a durable therapeutic effect.
See also: release
References in periodicals archive ?
In this work, we investigated the combined usages of ethyl cellulose (EC) and polyethylene glycol 1000 (PEG) for adjusting the release rates of tamoxifen citrate (TAM), whose sustained-release profile is highly desired by the patients [20].
Sustained-release coatings can consist of either water-insoluble or water-soluble polymers.
Ferrate Release Rate of Sustained-Release [K.sub.2]Fe[O.sub.4].
Previous studies, however, evaluated only men on sustained-release or intrathecal formulations and could not identify what aspect of opioid use may be contributing to hypogonadism.
Enteric-coated tablets, sustained-release or extended release coated capsules or tablets, sublingual and buccal tablets, and microencapsulated products should never be opened or crushed for administering through a feeding tube (3).
"Previously, we could not get these kinds of sustained-release treatments through the body's sticky mucus layers effectively."The new biodegradable particles comprise two parts made of molecules routinely used in existing medications.
Sustained-release T3 therapy requires careful monitoring of body temperature to make changes in dosage as the body adapts.
Some of the branded ingredients mentioned include Lyc-O-Mato tomato lycopene complex and MegaNatural-BP Grape Seed Extract, as well as sustained-release arginine and L-theanine.
* If you're concerned about flushing, ask for a sustained-release form of niacin also called "controlled release" or "slow release." Avoid "no flush" niacin--it's actually a fraudulent product that doesn't raise HDL.
Natrol's new supplements offer sustained-release, delayed-release, fast-and-prolonged-release, and biphasic-release (combining delayed release and immediate release) technologies to control the level of nutrients that the body absorbs, deposits, metabolizes and eliminates over time, thus maximizing health benefits.
In this paper, patients with a clinical diagnosis of degenerative joint disease for at least 1 month, and who were candidates for long-term therapy, received sustained-release paracetamol (acetaminophen 1.3 g 3 times daily), sustained-release celecoxib (200 mg daily or 200 mg twice daily), or placebo.